ASA: Dexamethasone Use During Cancer Surgery May Reduce Mortality
Intraoperative administration of dexamethasone linked to reduced 90-day mortality after surgery to remove solid tumors
Oncology
Keytruda Approved as First-Line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer
The approval was based on data from the phase 3 KEYNOTE-826 trial.
Verzenio Plus Endocrine Therapy Approved for HR+, HER2-, Early Breast Cancer
The approval is based on data from the phase 3 monarchE trial.
Drug Metabolism May Be Suppressed in Patients With Inflammatory Conditions
Suppressed drug metabolism was identified in patients with various inflammatory conditions.
Lung Cancer Treatment May Impact Daily Function in Older Adults
Life-space assessments may help older adults better understand how cancer treatment impacts their lives, authors say
Multimodel Anesthesia May Cut Opioid Usage After Head and Neck Cancer Surgery
Study authors analyzed the safety and efficacy of using MMA for patients undergoing head and neck surgery.
Tecartus Approved for Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
The approval was based on data from the phase 1/2 ZUMA-3 trial which evaluated Tecartus in 71 adults with relapsed or refractory B-cell precursor ALL.
Revised Guidelines Perpetuate Disparities in Lung Cancer Screening
In newly revised USPSTF guidelines, African American and Hispanic individuals continue to be less likely to be eligible for lung cancer screening
Taxane-Containing Chemo Associated With Persistent Alopecia
However, many patients experience improvements in hair density with standard alopecia treatments
Erbitux Plus Encorafenib Approved for BRAF V600E Mutation-Positive Metastatic Colorectal Cancer
The approval is supported by data from the phase 3 BEACON CRC trial in adults with BRAF V600E mutation-positive metastatic colorectal cancer with disease progression.
